Compounds and uses thereof
The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
1. A compound having the structure of Formula I:
wherein
B is
optionally substituted C 2 -C 9 heteroaryl, or C 2 -C 9 heterocyclyl;
R is
wherein R 1 is optionally substituted C 1 -C 3 alkyl or optionally substituted C 3 -C 6 cycloalkyl;
each R 3 and R 5 is, independently, selected from the group consisting of H, optionally substituted C 1 -C 6 alkyl, or optionally substituted C 1 -C 6 heteroalkyl;
R 4 is hydrogen, or optionally substituted C 1 -C 6 heteroalkyl; and
R 6 is optionally substituted C 6 -C 10 aryl or optionally substituted C 2 -C 9 heteroaryl
or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 , wherein the compound has the structure
wherein R 1 is optionally substituted C 1 -C 3 alkyl,
or a pharmaceutically acceptable salt thereof.
3. A compound having the structure of any one of compounds
and pharmaceutically acceptable salts thereof.
4. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.
5. The compound of claim 1 , wherein both R 3 and R 5 are H.
6. The compound of claim 1 , wherein R 4 is H,